Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection ; volume:19 ; number:1 ; day:2 ; month:12 ; year:2019 ; pages:1-8 ; date:12.2019
BMC cancer ; 19, Heft 1 (2.12.2019), 1-8, 12.2019
- Urheber
-
Tsai, Ming-Chao
Yen, Yi-Hao
Chang, Kuo-Chin
Hung, Chao-Hung
Chen, Chien-Hung
Lin, Ming-Tsung
Hu, Tsung-Hui
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-6397-3
- URN
-
urn:nbn:de:101:1-2020032523571022721054
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tsai, Ming-Chao
- Yen, Yi-Hao
- Chang, Kuo-Chin
- Hung, Chao-Hung
- Chen, Chien-Hung
- Lin, Ming-Tsung
- Hu, Tsung-Hui
- SpringerLink (Online service)
Ähnliche Objekte (12)
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)